- Academy of Medical Sciences grant to Dr Sofia Theodoropoulou 2 November 2017 Age-related macular degeneration (AMD) is a leading cause of irreversible blindness. Current treatments are available only for the very late stages of the wet form of AMD (caused by the aberrant growth of new vessels-angiogenesis) and only improve vision in 30% of those patients.
- Key discoveries offer significant hope of reversing antibiotic resistance 30 October 2017 Two recent studies led by the University of Bristol provide significant new hope in the fight against antibiotic resistance. By identifying what makes some bacteria resistant to the most commonly prescribed antibiotics, and how this can be reversed, the findings have demonstrated potentially life-saving consequences and could help reverse the tide of antibiotic resistance.
- Scientists pinpoint genetic risk factors for asthma, hay fever and eczema 24 October 2017 A major international study has pinpointed more than 100 genetic risk factors that explain why some people suffer from asthma, hay fever and eczema.
- Substantial investment to tackle challenges of African vector-borne plant diseases 5 October 2017 The University of Bristol has been awarded £2 million to lead a major new project that aims to tackle the devastation caused by vector-borne plant diseases in Africa.
- Bristol to lead national PhD training programme to tackle antimicrobial resistance 28 September 2017 In response to the urgent and global threat of antimicrobial resistance (AMR), the Medical Research Foundation (MRF), the charitable foundation of the Medical Research Council, has invested £2.85M in delivering the UK’s first nationwide PhD training programme to focus on this major health challenge.
- Interventions for reducing hepatitis C infection in people who inject drugs 26 September 2017 The first global review to quantify the impact of needle syringe programmes (NSP) and opioid substitution treatment (OST) in reducing the risk of becoming infected with the hepatitis C virus is published in Cochrane Library Drug and Alcohol Review Group and the journal Addiction. The study, has implications for millions of people who are 'at risk' from infection.
- New study aims to find the best moisturiser for treating eczema in children 22 September 2017 Researchers at the Universities of Bristol, Nottingham and Southampton have been awarded £1.4 million by the National Institute for Health Research (NIHR) Health Technology Assessment Programme to discover which is the best emollient (moisturiser) for treating childhood eczema.
- Study investigating effectiveness of The Lightning Process® programme to treat children with mild or moderate CFS or ME finds symptoms improve 21 September 2017 The first trial to investigate The Lightning Process® (LP) has been published in the Archives of Disease in Childhood. In this trial, the effectiveness of LP in addition to specialist medical care was compared to specialist medical care alone in children with mild or moderate chronic fatigue syndrome (also known as myalgic encephalomyelitis, CFS/ME).
- Surprising discovery - how the African tsetse fly really drinks your blood 21 September 2017 Researchers at the University of Bristol have been taking a close-up look at the biting mouthparts of the African tsetse fly as part of ongoing work on the animal diseases it carries.
- RCGP Research Paper of the Year award for CAPC-led study on urinary infections in children 18 September 2017 Research that helps GPs identify urinary tract infections in young children has been awarded a 2017 Royal College of General Practitioners (RCGP) Research Paper of the Year award.
Infection and immunity press releases
Press releases relating to infection and immunity on the University's central news pages.